Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,078.00
Bid: 12,076.00
Ask: 12,078.00
Change: 50.00 (0.42%)
Spread: 2.00 (0.017%)
Open: 12,036.00
High: 12,084.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

Mon, 29th Apr 2024 10:02

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

Deutsche Bank raises Experian target to 3,500 (2,918) pence - 'hold'

----------

Deutsche Bank starts JD Sports with 'hold' - price target 115 pence

----------

Barclays cuts JD Sports to 'equal weight' - price target 140 pence

----------

Deutsche Bank starts Frasers with 'buy' - price target 1,000 pence

----------

RBC raises AB Foods price target to 2,900 (2,700) pence - 'outperform'

----------

Barclays raises Unilever price target to 5,000 (4,600) pence - 'overweight'

----------

DZ Bank raises AstraZeneca price target to 12,200 (10,400) pence - 'hold'

----------

Barclays raises Beazley price target to 910 (790) pence - 'overweight'

----------

UBS raises NatWest price target to 340 (315) pence - 'buy'

----------

Berenberg raises NatWest price target to 350 (325) pence - 'buy'

----------

JPMorgan raises NatWest price target to 350 (330) pence - 'overweight'

----------

RBC raises NatWest price target to 355 (340) pence - 'sector perform'

----------

Bank of America raises NatWest price target to 335 (320) pence - 'buy'

----------

RBC raises Barclays price target to 260 (255) pence - 'outperform'

----------

Bank of America cuts London Stock Exchange price target to 10,700 (11,100) pence - 'buy'

----------

FTSE 250

----------

Deutsche Bank starts Watches of Switzerland with 'hold' - price target 370 pence

----------

Deutsche Bank starts Moonpig with 'hold' - price target 180 pence

----------

Deutsche Bank starts Dr Martens with 'hold' - price target 65 pence

----------

Deutsche Bank starts Currys with 'hold' - price target 58 pence

----------

Deutsche Bank starts AO World with 'buy' - price target 120 pence

----------

Barclays raises Lancashire price target to 790 (770) pence - 'equal weight'

----------

Barclays raises Hiscox price target to 1,340 (1,190) pence - 'equal weight'

----------

RBC cuts WH Smith price target to 1,500 (1,600) pence - 'outperform'

----------

HSBC reinitiates Serco with 'buy' - price target 210 pence

----------

SMALL CAP, AIM AND OTHER MAIN MARKET

----------

Deutsche Bank starts Motorpoint with 'buy' - price target 170 pence

----------

Deutsche Bank starts boohoo with 'sell' - price target 27 pence

----------

Deutsche Bank starts Mothercare with 'buy' - price target 12 pence

----------

Goldman Sachs raises Just Eat Takeaway price target to 16 (15.80) EUR - 'neutral'

----------

Peel Hunt raises Sabre Insurance to 'buy' - price target 210 pence

----------

Jefferies cuts AB Dynamics price target to 1,490 (1,500) pence - 'underperform'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All rights reserved.

More News
21 May 2024 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled a new "era of growth."

Read more
21 May 2024 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Read more
21 May 2024 07:34

AstraZeneca lays out plans to hit $80bn in revenues by 2030

(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.

Read more
20 May 2024 11:55

LONDON MARKET MIDDAY: Gold shines amid interest rate cut hopes

(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expected to show cooling prices.

Read more
20 May 2024 08:56

AstraZeneca to build $1.5-bln cancer drug plant in Singapore

Plans to build ADCs manufacturing facility in Singapore

*

Read more
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
17 May 2024 22:25

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

May 17 (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

Read more
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.